| Compound Information | |
|---|---|
| ID | 357 |
| TrivialName | (20E)-Ginsenoside F4 |
| Type | C17-side chain varied |
| MF | C₄₂H₇₀O₁₂ |
| MolecularWeight | 767.01 |
| IUPACName | (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2Z)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol |
| m/z | 811.4838 |
| Retention Time | 46.46 |
| CCS | 307.7 |
| Adducts | NT |
| Isomeric SMILES | O[C@H]1CC[C@@]2(C)C([C@@H](O[C@H]3[C@H](O[C@H]4[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O4)[C@@H](O)[C@H](O)[C@@H](CO)O3)C[C@]5(C)C2C[C@@H](O)C6[C@@]5(C)CCC6/C(C)=C/C/C=C(C)/C)C1(C)C |
| Canonical SMILES | CC(C)=CCC=C(C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3C(OC3OC(CO)C(O)C(O)C3OC3OC(C)C(O)C(O)C3O)CC12C |
| Source | Other |
| Functions | Inhibitory effect on human lymphocytoma, preventing cartillage collagen matrix breakdown in diseased tissues |
| Year | 1996 |
| References | |
| Structure |
|